Global Brother

Global Brother is a South Korean biotechnology company specializing in the development of exosome-based therapeutics and medical aesthetic solutions. The company leverages a proprietary platform for the high-purity isolation and mass production of exosomes, which are utilized to develop treatments for regenerative medicine and inflammatory diseases. Its primary R&D focus includes therapies for alopecia and atopic dermatitis, currently in the pre-clinical stages of development. In addition to its biotech pipeline, Global Brother maintains a commercial presence in the medical device market through the production and distribution of dermal fillers and specialized cosmetics. The company aims to integrate advanced extracellular vesicle technology with clinical aesthetics to address unmet needs in dermatology. By establishing strategic partnerships and expanding its manufacturing capabilities, Global Brother is positioning itself as a leader in the global exosome therapeutic space.